Hospice Fraud Stigma Could Deter 1.7M Medicare Patients from End-of-Life Care

Healthcare professionals are sounding alarms that the fraud crisis in hospice could roll back years of efforts to normalize end-of-life care. Patients like Mark Vantrease, who defied experts by living 11 months past his prognosis with hospice support, show what’s at risk if stigma drives people away from a benefit that improves quality of life and saves Medicare billions.

The hospice industry is reeling from a fraud crisis that could undermine patient trust and access to end-of-life care, experts warn, as the Centers for Medicare & Medicaid Services (CMS) imposes a six-month national moratorium on new hospice provider enrollments in Medicare, alongside heightened oversight in California. The crackdown, announced in May 2026, follows years of allegations that unscrupulous operators have exploited the Medicare hospice benefit—a $22 billion program serving over 1.7 million beneficiaries annually—by enrolling patients who are not terminally ill or billing for services never provided. While the intended goal is to root out fraud, the reputational damage may cause terminally ill patients to forgo hospice, increasing suffering and shifting costs to more expensive hospital settings.

“

The American Hospital Association estimates that hospice saves Medicare roughly $3,000 per patient in the last month of life compared to standard care; scaling those savings nationally amounts to billions.

Mark Vantrease, a 76-year-old Vietnam veteran with heart failure, lung disease, and liver damage, exemplifies the value of hospice. Given six months to live in 2025, he outlived that prognosis by 11 months under hospice care, which he said reminded him of the attention he received from medical staff during the war. His story highlights the gap between the idealized image of hospice and the fraud-tainted reality. Lauren Hunt, an associate professor at the UCSF Philip R. Lee Institute for Health Policy Studies, says the crisis has “done a lot of damage to the reputation of hospices overall and undone a lot of the progress that had been made in destigmatizing hospice.” Her warning reflects growing anxiety among legitimate providers that overly punitive regulations could shut down well-intentioned agencies, especially in communities already underserved by palliative care.

The fraud problem is concentrated in California, which has seen a surge in fly-by-night hospices. A 2024 report by the HHS Office of Inspector General found that one in five hospices in parts of Southern California had questionable billing patterns. The Trump administration’s allegations of unchecked fraud prompted the CMS moratorium, which halts new Medicare enrollments for hospice agencies nationwide and intensifies audits and site visits in California and several other states. For existing hospices, this means increased compliance costs and the threat of recoupments, potentially forcing smaller, community-based providers out of the market. That could reduce access for patients like Vantrease, who rely on local, trusted caregivers.

The moratorium’s broad-brush approach has drawn criticism. Policymakers are torn between protecting taxpayer dollars and preserving a benefit that improves quality of life for the terminally ill. A 2021 JAMA study found that hospice enrollment is associated with better symptom control, lower depression rates, and reduced ICU utilization at the end of life. Yet if the fraud narrative reduces enrollment—some surveys suggest minority patients are already less likely to choose hospice due to mistrust—the downstream effect could be more hospital deaths, higher Medicare spending on acute care, and worse outcomes. The American Hospital Association estimates that hospice saves Medicare roughly $3,000 per patient in the last month of life compared to standard care; scaling those savings nationally amounts to billions.